Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pseudogenes, such as the nerve growth factor receptor associated protein 1 pseudogene (ENSG00000238153), are nonfunctional segments of DNA that bear significant sequence similarity to protein-coding genes but lack the capability to produce a functional protein product. This specific pseudogene is a sequence derived from the nerve growth factor receptor associated protein 1 gene, but due to disruptive mutations (e.g., frameshifts, premature stop codons), it is incapable of generating the corresponding protein. Pseudogenes can be formed by gene duplication, retrotransposition, or as remnants of previously functional genes, and may occasionally be transcribed into RNA, sometimes playing minor regulatory roles at the RNA level. However, the vast majority—including this example—are considered functionally inert and do not serve as therapeutic targets nor as biomarkers for disease monitoring or treatment selection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nerve growth factor receptor associated protein 1 pseudogene.